Related references
Note: Only part of the references are listed.CREM-transgene mice: An animal model of atrial fibrillation and thrombogenesis
A. Bukowska et al.
THROMBOSIS RESEARCH (2018)
Histone deacetylase inhibitors protect against cisplatin-induced acute kidney injury by activating autophagy in proximal tubular cells
Jing Liu et al.
CELL DEATH & DISEASE (2018)
Inhibition of Histone Deacetylases Induces K+ Channel Remodeling and Action Potential Prolongation in HL-1 Atrial Cardiomyocytes
Patrick Lugenbiel et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Converse role of class I and class IIa HDACs in the progression of atrial fibrillation
Deli Zhang et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2018)
Hypercoagulability causes atrial fibrosis and promotes atrial fibrillation
Henri M. H. Spronk et al.
EUROPEAN HEART JOURNAL (2017)
A frameshift deletion in the sarcomere gene MYL4 causes early-onset familial atrial fibrillation
Daniel F. Gudbjartsson et al.
EUROPEAN HEART JOURNAL (2017)
Histone Deacetylase Inhibitors as Anticancer Drugs
Tomas Eckschlager et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Overlapping and Divergent Actions of Structurally Distinct Histone Deacetylase Inhibitors in Cardiac Fibroblasts
Katherine B. Schuetze et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
Activation of AMPK by berberine induces hepatic lipid accumulation by upregulation of fatty acid translocase CD36 in mice
You-Jin Choi et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2017)
Metabolic Considerations in Atrial Fibrillation - Mechanistic Insights and Therapeutic Opportunities
Masahide Harada et al.
CIRCULATION JOURNAL (2017)
Characterization of the Genetic Program Linked to the Development of Atrial Fibrillation in CREM-IbΔC-X Mice
Matthias D. Seidl et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2017)
Keeping up the balance: role of HDACs in cardiac proteostasis and therapeutic implications for atrial fibrillation
Deli Zhang et al.
CARDIOVASCULAR RESEARCH (2016)
Cardiac expression of the CREM repressor isoform CREM-IbΔC-X in mice leads to arrhythmogenic alterations in ventricular cardiomyocytes
J. S. Schulte et al.
BASIC RESEARCH IN CARDIOLOGY (2016)
Cardiac Magnetic Resonance-Measured Left Atrial Volume and Function and Incident Atrial Fibrillation Results From MESA (Multi-Ethnic Study of Atherosclerosis)
Mohammadali Habibi et al.
CIRCULATION-CARDIOVASCULAR IMAGING (2016)
Targeting histone deacetylases: A novel therapeutic strategy for atrial fibrillation
Baigalmaa Lkhagva et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
Epigenetic regulation of cardiac fibrosis
Matthew S. Stratton et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2016)
Triggered activity in atrial myocytes is influenced by Na+/Ca2+ exchanger activity in genetically altered mice
N. Boegeholz et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2016)
Valproic acid selectively increases vascular endothelial tissue-type plasminogen activator production and reduces thrombus formation in the mouse
P. Larsson et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Up-regulation of miR-31 in human atrial fibrillation begets the arrhythmia by depleting dystrophin and neuronal nitric oxide synthase
Svetlana N. Reilly et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Class I Histone Deacetylase Inhibition for the Treatment of Sustained Atrial Fibrillation
Mitsuru Seki et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes
Jenny Y. Y. Ooi et al.
EPIGENETICS (2015)
Cardiac Fibrosis in Patients With Atrial Fibrillation Mechanisms and Clinical Implications
Mikhail S. Dzeshka et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Atrial remodeling, fibrosis, and atrial fibrillation
Jose Jalife et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2015)
Left Atrial Transcriptional Changes Associated With Atrial Fibrillation Susceptibility and Persistence
Amrish Deshmukh et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2015)
Activation of Histone Deacetylase-6 Induces Contractile Dysfunction Through Derailment of α-Tubulin Proteostasis in Experimental and Human Atrial Fibrillation
Deli Zhang et al.
CIRCULATION (2014)
Ryanodine Receptor-Mediated Calcium Leak Drives Progressive Development of an Atrial Fibrillation Substrate in a Transgenic Mouse Model
Na Li et al.
CIRCULATION (2014)
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
Craig T. January et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Valproic Acid Is a Novel Activator of AMP-Activated Protein Kinase and Decreases Liver Mass, Hepatic Fat Accumulation, and Serum Glucose in Obese Mice
Lindsay B. Avery et al.
MOLECULAR PHARMACOLOGY (2014)
Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060
Bouwe P. Krijthe et al.
EUROPEAN HEART JOURNAL (2013)
Overexpression of cAMP-response element modulator causes abnormal growth and development of the atrial myocardium resulting in a substrate for sustained atrial fibrillation in mice
Paulus Kirchhof et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Cardiac phenotype of Duchenne Muscular Dystrophy: Insights from cellular studies
Natalia Shirokova et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2013)
Histone deacetylase inhibitors stimulate tissue-type plasminogen activator production in vascular endothelial cells
Pia Larsson et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2013)
Whole-body pharmacokinetics of HDAC inhibitor drugs, butyric acid, valproic acid and 4-phenylbutyric acid measured with carbon-11 labeled analogs by PET
Sung Won Kim et al.
NUCLEAR MEDICINE AND BIOLOGY (2013)
Proteomic analyses of age related changes in A.BY/SnJ mouse hearts
Krishnatej Nishtala et al.
PROTEOME SCIENCE (2013)
CREB critically regulates action potential shape and duration in the adult mouse ventricle
J. S. Schulte et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2012)
Therapeutic Potential for HDAC Inhibitors in the Heart
Timothy A. McKinsey
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 52 (2012)
AMP-Activated Protein Kinase Potential Role in Cardiac Electrophysiology and Arrhythmias
Masahide Harada et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2012)
Novel molecular targets for atrial fibrillation therapy
Dobromir Dobrev et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Substrate Modifications Precede the Development of Atrial Fibrillation After Cardiac Surgery: A Proteomic Study
Antonios Kourliouros et al.
ANNALS OF THORACIC SURGERY (2011)
Desmoglein 2 mutant mice develop cardiac fibrosis and dilation
Claudia A. Krusche et al.
BASIC RESEARCH IN CARDIOLOGY (2011)
Mechanical Coupling Between Myofibroblasts and Cardiomyocytes Slows Electric Conduction in Fibrotic Cell Monolayers
Susan A. Thompson et al.
CIRCULATION (2011)
Roles and Targets of Class I and IIa Histone Deacetylases in Cardiac Hypertrophy
Hae Jin Kee et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
Isoform-selective HDAC inhibitors: Closing in on translational medicine for the heart
Timothy A. McKinsey
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)
Plasma von Willebrand Factor Levels Are an Independent Risk Factor for Adverse Events Including Mortality and Major Bleeding in Anticoagulated Atrial Fibrillation Patients
Vanessa Roldan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
CREB and the CRTC co-activators: sensors for hormonal and metabolic signals
Judith Y. Altarejos et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
Pathophysiological Mechanisms of Atrial Fibrillation: A Translational Appraisal
Ulrich Schotten et al.
PHYSIOLOGICAL REVIEWS (2011)
Return to the fetal gene program A suggested metabolic link to gene expression in the heart
Heinrich Taegtmeyer et al.
ANALYSIS OF CARDIAC DEVELOPMENT: FROM EMBRYO TO OLD AGE (2010)
Antiepileptic treatment in patients with epilepsy and other comorbidities
J. Ruiz-Gimenez et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2010)
Histone-deacetylase inhibition reverses atrial arrhythmia inducibility and fibrosis in cardiac hypertrophy independent of angiotensin
Fang Liu et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2008)
Initial management of epilepsy
Jacqueline A. French et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees?
G. Rosenberg
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
The transcriptional repressor cAMP response element modulator α interacts with histone deacetylase 1 to repress promoter activity
Klaus Tenbrock et al.
JOURNAL OF IMMUNOLOGY (2006)
Inhibition of basic leucine zipper transcription is a major mediator of atrial dilatation
Izhak Kehat et al.
CARDIOVASCULAR RESEARCH (2006)
Reprogramming of the human atrial transcriptome in permanent atrial fibrillation -: Expression of a ventricular-like genomic signature
AS Barth et al.
CIRCULATION RESEARCH (2005)
Heart-directed expression of a human cardiac isoform of cAMP-response element modulator in transgenic mice
FU Müller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Pathophysiological findings in a model of persistent atrial fibrillation and severe congestive heart failure
A Bauer et al.
CARDIOVASCULAR RESEARCH (2004)
Histone deacetylase is a target of valproic acid-mediated cellular differentiation
N Gurvich et al.
CANCER RESEARCH (2004)
The activity of antiepileptic drugs as histone deacetylase inhibitors
S Eyal et al.
EPILEPSIA (2004)
Prolonged atrial action potential durations and polymorphic atrial tachyarrhythmias in patients with long QT syndrome
P Kirchhof et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2003)
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
M Göttlicher et al.
EMBO JOURNAL (2001)
Time course of atrial fibrillation-induced cellular structural remodeling in atria of the goat
J Ausma et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2001)
Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen
CJ Phiel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Transgenic mice with cardiac-specific expression of activating transcription factor 3, a stress-inducible gene, have conduction abnormalities and contractile dysfunction
Y Okamoto et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Structural changes of atrial myocardium during chronic atrial fibrillation
VLJL Thijssen et al.
CARDIOVASCULAR PATHOLOGY (2000)
Share Paper
